Synthesis, Transport and Pharmacokinetics of 5′-Amino Acid Ester Prodrugs of 1-β-d-Arabinofuranosylcytosine

Molecular Pharmaceutics - Tập 6 Số 1 - Trang 315-325 - 2009
Yongbing Sun1, Jin Sun1, Shi‐Liang Shi1, Yongkui Jing1, Shiliang Yin1, Ying Chen1, Gang Li1, Youjun Xu1, Zhonggui He1
1Departments of Biopharmaceutics, Pharmacology, and Medicinal Chemistry, Shenyang Pharmaceutical University, Shenyang, 110016, China, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033, Japan, Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029-6547, and Institute of Pharmacology Toxicology, Academy of Military Medical Sciences, Beijing, 100850, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pallavicini M. G., 1984, Pharmacol. Ther., 25, 207, 10.1016/0163-7258(84)90044-5

Rustum M., 1992, Pharmacol. Ther., 56, 307, 10.1016/0163-7258(92)90022-R

Grant S., 1997, Adv. Cancer Res., 72, 197, 10.1016/S0065-230X(08)60703-4

Furth J. J., 1968, Cancer Res., 28, 2061

Graham F. L., 1970, Cancer Res., 30, 2636

Major P. P., 1981, Proc. Natl. Acad. Sci. U.S.A., 78, 3235, 10.1073/pnas.78.5.3235

Kufe D. W., 1980, J. Biol. Chem., 255, 8997, 10.1016/S0021-9258(19)70512-2

Capizzi R. L., 1991, Semin. Hematol., 28, 54

Gray G. D., 1968, Transplantation, 6, 818, 10.1097/00007890-196810000-00002

Hadfield A. F., 1984, Adv. Pharmacol. Chemother., 20, 21, 10.1016/S1054-3589(08)60264-1

Cheon E. P., 2006, J. Pharm. Pharmcol., 58, 927, 10.1211/jpp.58.7.0007

Cheon E. P., 2007, Acta Pharmacol. Sin., 28, 268, 10.1111/j.1745-7254.2007.00474.x

Gray G. D., 1972, Biochem. Pharmacol., 21, 465, 10.1016/0006-2952(72)90319-X

Han H. K., 1998, Pharm. Res., 15, 1154, 10.1023/A:1011919319810

Oh, D. M.; Han, H. K.; Amidon, G. L.Drug transport and targeting;Kluwer Academic/Plenum:New York, 1999; pp59−88.

Han H. K., 2000, AAPS PharmSci., 2, 1, 10.1208/ps020101

Rubio-Aliaga I., 2002, Trends Pharmacol. Sci., 23, 434, 10.1016/S0165-6147(02)02072-2

Nielsen C. U., 2002, Expert Opin. Ther. Pat., 12, 1329, 10.1517/13543776.12.9.1329

Beauchamp L. M., 1992, Antiviral Chem. Chemother., 3, 157, 10.1177/095632029200300305

Beutner K. R., 1995, Antiviral Res., 28, 281, 10.1016/0166-3542(95)00066-6

Balimane P. V., 1998, Biochem. Biophys. Res. Commun., 250, 246, 10.1006/bbrc.1998.9298

Bueno A. B., 2005, J. Med. Chem., 48, 5305, 10.1021/jm050235r

Perkins E. J., 2007, Drug Metab. Dispos., 35, 1903, 10.1124/dmd.107.016154

Wang F., 2006, J. Nat. Prod., 69, 807, 10.1021/np050371z

Gao, J.; Hugger, E. D.; Beck-Westermeyer, M. S.; Borchardt, R. T.Esimating intestinal permeation of compounds using Caco-2 cell monolayers. InCurrent Protocol in Pharmacology;Enna, S. J.; Williams, M.; Ferkany, J. W.; Kenakin, T.; Porsolt, R. D.; Sullivan, J. P.Eds.Wiley:New York, 2000; pp721−3.

Khan S. I., 2003, Planta Med., 69, 1009

Khan S. I., 2004, Chem. Pharm. Bull., 52, 394, 10.1248/cpb.52.394

Konishi Y., 2002, Biosci. Biotechnol. Biochem., 66, 2449, 10.1271/bbb.66.2449

Sakai M., 1997, J. Pharm. Sci., 86, 779, 10.1021/js960529n

Terada T., 1997, Am. J. Physiol., 273, F706−11

Hindlet P., 2007, J. Pharmacol. Exp. Ther., 323, 192, 10.1124/jpet.107.125799

Nduati V., 2007, J. Biol. Chem., 282, 1359, 10.1074/jbc.M604267200

Lorenzi P. L., 2005, J. Pharmacol. Exp. Ther., 314, 883, 10.1124/jpet.104.082412

Sun Y. B., 2008, J. Chromatogr. B., 870, 121, 10.1016/j.jchromb.2008.05.033

Landowski C. P., 2005, Pharm. Res., 22, 1510, 10.1007/s11095-005-6156-9

Song X. Q., 2005, Mol. Pharmaceutics, 2, 157, 10.1021/mp049888e

Song X. Q., 2005, J. Med. Chem., 48, 1274, 10.1021/jm049450i

Chen Z., 2003, J. Physiol., 546, 349, 10.1113/jphysiol.2002.026500

Granero G. E., 2006, Int. J. Pharm., 317, 14, 10.1016/j.ijpharm.2006.01.050

Wan S. H., 1974, Cancer Res., 34, 392

Tsume Y., 2008, Mol. Pharmaceutics, 5, 717, 10.1021/mp800008c

Li F. J., 2008, J. Pharm. Sci., 97, 1109, 10.1002/jps.21047